Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Firm Flouting Ephedra Ban Faces Product Seizure By U.S. Marshals

This article was originally published in The Tan Sheet

Executive Summary

An FDA-prompted seizure of ephedra products could make it more likely Hi-Tech pharmaceuticals' suit against the FDA over the ephedra ban will go to court, according to the firm
Advertisement

Related Content

Hi-Tech CEO Could Face Jail For Violating Court Order To Recall Weight Loss Products
Hi-Tech CEO Could Face Jail For Violating Court Order To Recall Weight Loss Products
Enforcement In Brief
Enforcement In Brief
Ephedra seizure
“No Evidence” Exists That Ephedra Ban Shifted Burden Of Proof, Agency Says
FDA Appeals Utah Ephedra Court Ruling, Defends Use Of Risk/Benefit Analysis
Utah Court Overturns Ephedra Ban For Low-Dose Products
Ephedrine supplements seized
Dietary Supplement Obesity, Erectile Dysfunction Claims Barred By Court

Topics

Advertisement
UsernamePublicRestriction

Register

PS099003

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel